Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome.
Pandolfi L, Fusco R, Frangipane V, D'Amico R, Giustra M, Bozzini S, Morosini M, D'Amato M, Cova E, Ferrario G, Morbini P, Colombo M, Prosperi D, Viglio S, Piloni D, Di Paola R, Cuzzocrea S, Meloni F. Pandolfi L, et al. Among authors: cova e. Sci Rep. 2020 Nov 26;10(1):20726. doi: 10.1038/s41598-020-77828-y. Sci Rep. 2020. PMID: 33244143 Free PMC article.
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents.
Cova E, Inghilleri S, Pandolfi L, Morosini M, Magni S, Colombo M, Piloni D, Finetti C, Ceccarelli G, Benedetti L, Cusella MG, Agozzino M, Corsi F, Allevi R, Mrakic-Sposta S, Moretti S, De Gregori S, Prosperi D, Meloni F. Cova E, et al. Nanotoxicology. 2017 May;11(4):534-545. doi: 10.1080/17435390.2017.1317862. Epub 2017 Apr 27. Nanotoxicology. 2017. PMID: 28415888
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.
Codullo V, Cova E, Pandolfi L, Breda S, Morosini M, Frangipane V, Malatesta M, Calderan L, Cagnone M, Pacini C, Cavagna L, Recalde H, Distler JHW, Giustra M, Prosperi D, Colombo M, Meloni F, Montecucco C. Codullo V, et al. Among authors: cova e. J Control Release. 2019 Sep 28;310:198-208. doi: 10.1016/j.jconrel.2019.08.015. Epub 2019 Aug 17. J Control Release. 2019. PMID: 31430501
Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients.
Piloni D, Morosini M, Magni S, Balderacchi A, Inghilleri S, Cova E, Oggionni T, Frangipane V, Pandolfi L, Scudeller L, Meloni F. Piloni D, et al. Among authors: cova e. Transpl Immunol. 2019 Dec;57:101245. doi: 10.1016/j.trim.2019.101245. Epub 2019 Sep 14. Transpl Immunol. 2019. PMID: 31526864
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
Pandolfi L, Fossali T, Frangipane V, Bozzini S, Morosini M, D'Amato M, Lettieri S, Urtis M, Di Toro A, Saracino L, Percivalle E, Tomaselli S, Cavagna L, Cova E, Mojoli F, Bergomi P, Ottolina D, Lilleri D, Corsico AG, Arbustini E, Colombo R, Meloni F. Pandolfi L, et al. Among authors: cova e. BMC Pulm Med. 2020 Nov 16;20(1):301. doi: 10.1186/s12890-020-01343-z. BMC Pulm Med. 2020. PMID: 33198751 Free PMC article.
44 results